The FDA-approved Rezdiffra product is available as 60 mg, 80 mg and 100 mg tablets.
| Strength | Reference-product status |
|---|---|
| 60 mg | FDA-labeled Rezdiffra strength |
| 80 mg | FDA-labeled Rezdiffra strength |
| 100 mg | FDA-labeled Rezdiffra strength |
For the reference product, the recommended dose is determined by body weight: 80 mg once daily for patients weighing less than 100 kg and 100 mg once daily for patients weighing 100 kg or more.
The Resiliva website brief identifies 80 mg and 100 mg strengths. Whether Resiliva is actually manufactured in those strengths, and whether it has additional strengths, requires confirmation from the product packaging and regulatory documentation.
Strength is not the same as prescribed dose
A tablet strength describes the amount of active ingredient in the dosage unit. The appropriate daily dose depends on the applicable prescribing information and patient-specific factors.